🇺🇸 mouse nerve growth factor in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Abdominal Discomfort — 1 report (10%)
  2. Alanine Aminotransferase Increased — 1 report (10%)
  3. Ammonia Increased — 1 report (10%)
  4. Ascites — 1 report (10%)
  5. Aspartate Aminotransferase Increased — 1 report (10%)
  6. Blood Alkaline Phosphatase Increased — 1 report (10%)
  7. Blood Bilirubin Increased — 1 report (10%)
  8. Depressed Level Of Consciousness — 1 report (10%)
  9. Electrolyte Imbalance — 1 report (10%)
  10. Erythema — 1 report (10%)

Source database →

mouse nerve growth factor in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is mouse nerve growth factor approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for mouse nerve growth factor in United States?

Zhujiang Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.